- In today’s scenario, the Indian pharmaceutical sector has been focusing on R&D activities and to enhance their launch of new products and compete in

  the highly regulated market.

- This situation has led to a large amount of investments in R&D centers by Indian pharmaceuticals.

- To support this cause of developing new formulations, Pam Pac, with the introduction of the Model ‘MINIBLIS’ blister packing machine offers a

   versatile solution for producing all forms of blister packs, vital for R&D testing and clinical exhibit batches, thus opening up windows of opportunity for

   this segment.

- Designed for R&D / Clinical trials and exhibit batches. 
- Versatility to produce all configurations of blisters –
- PVC/PVdC, ALU/ALU and up gradable to Tropical blisters. 
- Modular balcony construction complying to cGMP standards.
- Facility of auto feeding for testing product characteristics for feeding. 
- Ensures equivalent quality of blisters, when scale up to commercial production.
- Snap in type change parts for quick change over.